We next used a surrogate for mycoplasma infection by treating cells with a synthetic lipoprotein mimetic, Pam2CSK4, which has been shown to cause NF-κB activation in other cell lines (37). This evidence concerns the gene NFKB1 and Mycoplasmoides infection.